Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8352)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2018 (publication date) through Jan 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takakura K, Oikawa T, Tomita Y, Mizuno Y, Nakano M, Saeki C, Torisu Y, Saruta M. Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma. World J Gastroenterol 2018; 24(18): 1989-1994 [PMID: 29760542 DOI: 10.3748/wjg.v24.i18.1989] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i18/1989.htm |
| Number | Citing Articles |
| 1 |
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
|
| 2 |
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1148934
|
| 3 |
Juliane I. Beier, Valentina Medici, Sean Spencer, Weiguo Fan, Natalie J. Török. Metabolic Steatotic Liver Disease. 2024; : 41 doi: 10.1016/B978-0-323-99649-5.00006-6
|
| 4 |
Utibe-Abasi S. Udoh, Moumita Banerjee, Pradeep K. Rajan, Juan D. Sanabria, Gary Smith, Mathew Schade, Jacqueline A. Sanabria, Yuto Nakafuku, Komal Sodhi, Sandrine V. Pierre, Joseph I. Shapiro, Juan R. Sanabria. Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(13): 7359 doi: 10.3390/ijms23137359
|
| 5 |
Edwige Schreyer, Cathy Obringer, Nadia Messaddeq, Bruno Kieffer, Paul Zimmet, Alexander Fleming, Tarekegn Geberhiwot, Vincent Marion. PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo. Diabetes 2022; 71(9): 2034 doi: 10.2337/db22-0058
|
| 6 |
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, Geraldine J. Ooi, Matthew J. Watt, Michael Karin. Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?. Cell Metabolism 2019; 29(1): 18 doi: 10.1016/j.cmet.2018.10.012
|
| 7 |
R. Rama Suresh, Shanu Jain, Zhoumou Chen, Dilip K. Tosh, Yanling Ma, Maren C. Podszun, Yaron Rotman, Daniela Salvemini, Kenneth A. Jacobson. Design and in vivo activity of A3 adenosine receptor agonist prodrugs. Purinergic Signalling 2020; 16(3): 367 doi: 10.1007/s11302-020-09715-0
|
| 8 |
Yewei Liu, Shuncong Wang, Xiaohui Zhao, Yuanbo Feng, Guy Bormans, Johan Swinnen, Raymond Oyen, Gang Huang, Yicheng Ni, Yue Li. Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation. Diagnostics 2020; 10(2): 78 doi: 10.3390/diagnostics10020078
|
| 9 |
Hongjun Wang, Rachele Ciccocioppo, Shuji Terai, Sara Shoeibi, Gianluca Carnevale, Giulia De Marchi, Atsunori Tsuchiya, Soichi Ishii, Takafumi Tonouchi, Kaito Furuyama, Yuan Yang, Masaki Mito, Hiroyuki Abe, Rosanna Di Tinco, Vincenzo Cardinale. Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights. Cytotherapy 2024; doi: 10.1016/j.jcyt.2024.11.008
|
| 10 |
Daniel Jahn, Stefan Kircher, Heike M. Hermanns, Andreas Geier. Animal models of NAFLD from a hepatologist's point of view. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 943 doi: 10.1016/j.bbadis.2018.06.023
|
| 11 |
Noriko Suzuki-Kemuriyama, Akari Abe, Sae Nakane, Megumi Yuki, Katsuhiro Miyajima, Dai Nakae, Fei Luo. Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes. PLOS ONE 2023; 18(8): e0287657 doi: 10.1371/journal.pone.0287657
|
| 12 |
Tsutomu Wada, Yuki Takeda, Akira Okekawa, Go Komatsu, Yuichi Iwasa, Yasuhiro Onogi, Ichiro Takasaki, Takeru Hamashima, Masakiyo Sasahara, Hiroshi Tsuneki, Toshiyasu Sasaoka. Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-75713-6
|
| 13 |
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. World Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
|
| 14 |
Scott A. Reisman, Deborah A. Ferguson, Chun‐Yue I. Lee, Joel W. Proksch. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. Journal of Biochemical and Molecular Toxicology 2020; 34(9) doi: 10.1002/jbt.22526
|